Canada markets open in 7 hours 22 minutes

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.8000-0.0500 (-2.70%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
130
163
140
367
437
Cost of Revenue
919
806
893
884
1,183
Gross Profit
-789
-643
-753
-517
-746
Operating Expenses
Research Development
6,119
5,720
4,651
4,778
4,098
Selling General and Administrative
8,924
8,654
7,039
6,201
6,572
Total Operating Expenses
15,043
14,374
11,690
10,979
10,670
Operating Income or Loss
-15,832
-15,017
-12,443
-11,496
-11,416
Interest Expense
168
672
427
502
139
Total Other Income/Expenses Net
-967
1,070
3,248
2,139
3,208
Income Before Tax
-16,695
-14,400
-9,533
-9,813
-8,259
Income from Continuing Operations
-16,695
-14,400
-9,533
-9,813
-8,259
Net Income
-16,695
-14,400
-9,533
-9,813
-8,259
Net Income available to common shareholders
-16,695
-14,400
-9,533
-9,813
-8,259
Basic EPS
-
-0.45
-2.62
-9.68
-12.76
Diluted EPS
-
-0.45
-2.62
-9.68
-12.76
Basic Average Shares
-
31,843
3,643
1,004
651.721
Diluted Average Shares
-
31,843
3,643
1,004
651.721
EBITDA
-
-12,995
-8,314
-8,433
-7,109